These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31930476)

  • 1. Impact of enzymatic reduction on bivalent bispecific antibody fragmentation and loss of product purity upon reoxidation.
    Swope N; Chung WK; Cao M; Motabar D; Liu D; Ahuja S; Handlogten M
    Biotechnol Bioeng; 2020 Apr; 117(4):1063-1071. PubMed ID: 31930476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and analysis of scFv-IgG bispecific antibody size variants.
    Cao M; Wang C; Chung WK; Motabar D; Wang J; Christian E; Lin S; Hunter A; Wang X; Liu D
    MAbs; 2018; 10(8):1236-1247. PubMed ID: 30130449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion reduces bispecific antibody aggregation via mitigating mitochondrial dysfunction-induced glutathione oxidation and ER stress in CHO cells.
    Sinharoy P; Aziz AH; Majewska NI; Ahuja S; Handlogten MW
    Sci Rep; 2020 Oct; 10(1):16620. PubMed ID: 33024175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culture temperature modulates half antibody and aggregate formation in a Chinese hamster ovary cell line expressing a bispecific antibody.
    Gomez N; Wieczorek A; Lu F; Bruno R; Diaz L; Agrawal NJ; Daris K
    Biotechnol Bioeng; 2018 Dec; 115(12):2930-2940. PubMed ID: 30036451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocell targeting using engineered bispecific antibodies.
    Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
    MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a Novel Bispecific Antibody With Improved Conformational and Chemical Stability.
    Manikwar P; Mulagapati SHR; Kasturirangan S; Moez K; Rainey GJ; Lobo B
    J Pharm Sci; 2020 Jan; 109(1):220-232. PubMed ID: 31288034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modular IgG-scFv bispecific antibody topology.
    Orcutt KD; Ackerman ME; Cieslewicz M; Quiroz E; Slusarczyk AL; Frangioni JV; Wittrup KD
    Protein Eng Des Sel; 2010 Apr; 23(4):221-8. PubMed ID: 20019028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability.
    Chung WK; Russell B; Yang Y; Handlogten M; Hudak S; Cao M; Wang J; Robbins D; Ahuja S; Zhu M
    Biotechnol Bioeng; 2017 Jun; 114(6):1264-1274. PubMed ID: 28186329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-column disulfide bond formation of monoclonal antibodies during Protein A chromatography eliminates low molecular weight species and rescues reduced antibodies.
    Tan Z; Ehamparanathan V; Ren T; Tang P; Hoffman L; Kuang J; Liu P; Huang C; Du C; Tao L; Chemmalil L; Lewandowski A; Ghose S; Li ZJ; Liu S
    MAbs; 2020; 12(1):1829333. PubMed ID: 33016217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G
    De Nardis C; Hendriks LJA; Poirier E; Arvinte T; Gros P; Bakker ABH; de Kruif J
    J Biol Chem; 2017 Sep; 292(35):14706-14717. PubMed ID: 28655766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using hydrogen peroxide to prevent antibody disulfide bond reduction during manufacturing process.
    Du C; Huang Y; Borwankar A; Tan Z; Cura A; Yee JC; Singh N; Ludwig R; Borys M; Ghose S; Mussa N; Li ZJ
    MAbs; 2018 Apr; 10(3):500-510. PubMed ID: 29336721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties.
    Schanzer JM; Wartha K; Croasdale R; Moser S; Künkele KP; Ries C; Scheuer W; Duerr H; Pompiati S; Pollman J; Stracke J; Lau W; Ries S; Brinkmann U; Klein C; Umana P
    J Biol Chem; 2014 Jul; 289(27):18693-706. PubMed ID: 24841203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione and thioredoxin systems contribute to recombinant monoclonal antibody interchain disulfide bond reduction during bioprocessing.
    Handlogten MW; Zhu M; Ahuja S
    Biotechnol Bioeng; 2017 Jul; 114(7):1469-1477. PubMed ID: 28262915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing.
    Metz S; Panke C; Haas AK; Schanzer J; Lau W; Croasdale R; Hoffmann E; Schneider B; Auer J; Gassner C; Bossenmaier B; Umana P; Sustmann C; Brinkmann U
    Protein Eng Des Sel; 2012 Oct; 25(10):571-80. PubMed ID: 22976197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full-length recombinant antibodies from
    Rashid MH
    MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatographic behavior of bivalent bispecific antibodies on cation exchange columns. II. Biomolecular perspectives.
    Kimerer LK; Pabst TM; Hunter AK; Carta G
    J Chromatogr A; 2019 Sep; 1601():133-144. PubMed ID: 31054833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bispecific antibody derivatives based on full-length IgG formats.
    Grote M; Haas AK; Klein C; Schaefer W; Brinkmann U
    Methods Mol Biol; 2012; 901():247-63. PubMed ID: 22723106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization and kinetic modeling of interchain disulfide bond reoxidation of monoclonal antibodies in bioprocesses.
    Tang P; Tan Z; Ehamparanathan V; Ren T; Hoffman L; Du C; Song Y; Tao L; Lewandowski A; Ghose S; Li ZJ; Liu S
    MAbs; 2020; 12(1):1829336. PubMed ID: 33031716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects.
    Hutterer KM; Hong RW; Lull J; Zhao X; Wang T; Pei R; Le ME; Borisov O; Piper R; Liu YD; Petty K; Apostol I; Flynn GC
    MAbs; 2013; 5(4):608-13. PubMed ID: 23751615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair.
    Strop P; Ho WH; Boustany LM; Abdiche YN; Lindquist KC; Farias SE; Rickert M; Appah CT; Pascua E; Radcliffe T; Sutton J; Chaparro-Riggers J; Chen W; Casas MG; Chin SM; Wong OK; Liu SH; Vergara G; Shelton D; Rajpal A; Pons J
    J Mol Biol; 2012 Jul; 420(3):204-19. PubMed ID: 22543237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.